24 Therefore, considering that GLP-1R is widely distributed in the body, that COPD and diabetes interact with each other and share common pathogenic mechanisms, and that GLP-1 and its receptor agonists have been widely used in diabetic patients and have demonstrated hypoglycemic, pro-inflammatory and anti-inflammatory factors, oxidative stress, neurogenesis and vascular protection, 33 then GLP-1 and its receptor agonists also have a role to play in COPD patients
However, previous research suggested a lack of improvement in SF-36 scores (deteriorated or remained stable) following interventions demonstrating modest improvement in A1C levels, blood lipid, and blood pressure in patients with T2DM
Build lasting confidence
ASK1, apoptotic signal-regulating kinase 1
In terms of adverse effects, sitagliptin is better tolerated and has a lower incidence of gastrointestinal adverse events compared to GLP-1 analogues
As of mid-2026, the company carries over 2,300 prescription products delivered by mail to patients nationwide, and is actively working with trade name manufacturers to add both single-source brands and specialty biologics to its pharmacy
